Roche (SWX:ROG) Stock Fair Value Edges Higher As Analysts Weigh Pipeline Growth
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Roche…
UBS Group Q2 Earnings Call Highlights
UBS Group (NYSE:UBS) reported second-quarter 2026 net profit of CHF 2.8 billion and earnings per share of CHF…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc](https://www.europesays.com/ch/wp-content/uploads/2026/07/1785239847_https2F2Fmedia.zenfs_.com2Fen2Fglobenewswire.com2F84b0110bbf60eb8397db0461bc3549c4-380x220.jpeg)
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Key figures CHF millions % change January–June 2026 2025 At CER1 In CHF In USD Group sales 30,364…
Nestle’s Turnaround Still Has a Bitter Aftertaste
Nestle’s Turnaround Still Has a Bitter Aftertaste – Moby THE GIST Our analysts just identified a stock with…
Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum
Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 30.4 billion ($38.6 billion) in the first…
Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum
Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 30.4 billion ($38.6 billion) in the first…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc](https://www.europesays.com/ch/wp-content/uploads/2026/07/1147849-380x220.png)
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2,…
Roche’s 2024 Sales and Earnings Beat, Key Drugs Perform Well
Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for 2025.…
ABB (SWX:ABBN) Stock Valuation After A 74% One Year Total Return
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. What…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc](https://www.europesays.com/ch/wp-content/uploads/2026/06/1781246635_d295bae68c32358ba6ac888e76c1cca2.png)
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
F. Hoffmann-La Roche Ltd Group sales were +6% at constant exchange rates (CER)1, -5% when reported in CHF and…
Typically Swiss
When start-ups operate in fields traditionally associated with Switzerland, it facilitates communication. And there are more such fields…
Euro Fights “Two-Front War” Against Sterling and Swiss Franc
At first glance, Euro looks healthy this week. Dollar is falling, oil prices are collapsing, and risk appetite…